Author

Suzanne Galkin

Observed name: S. Galkin

Observed institutions: Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center

OpenAlex ID: A5013219167

In Vivo Correlates of Response for Phase I Trial of Oral Tipifarnib (T) Combined with Oral Etoposide (E) for Adults Age ≥ 70 with Newly Diagnosed Acute Myelogenous Leukemia (AML) Who Are Not Candidates for Traditional Cytotoxic Chemotherapy (TCC).

2007 · Rebecca M. Ricklis, Judith E. Karp, et al. · Blood · 5

Correlation of RASGRP1:APTX expression assay with response to tipifarnib plus etoposide in elderly patients with newly diagnosed AML.

2011 · T. I. Vener, C. Derecho, et al. · Journal of Clinical Oncology · 1

Нейропротективная терапия хронической цереброваскулярной патологии

2014 · А. В. Анисимова, Т. И. Колесникова, et al.

Works count: 4

Citation count: 6

H-index: 1

I10-index: